{
  "tweet": {
    "edit_info": {
      "initial": {
        "editTweetIds": [
          "1760237715873001582"
        ],
        "editableUntil": "2024-02-21T10:39:09.756Z",
        "editsRemaining": "5",
        "isEditEligible": false
      }
    },
    "retweeted": false,
    "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>",
    "entities": {
      "hashtags": [],
      "symbols": [],
      "user_mentions": [
        {
          "name": "New York Magazine",
          "screen_name": "NYMag",
          "indices": [
            "3",
            "9"
          ],
          "id_str": "45564482",
          "id": "45564482"
        }
      ],
      "urls": []
    },
    "display_text_range": [
      "0",
      "139"
    ],
    "favorite_count": "0",
    "id_str": "1760237715873001582",
    "truncated": false,
    "retweet_count": "0",
    "id": "1760237715873001582",
    "created_at": "Wed Feb 21 09:39:09 +0000 2024",
    "favorited": false,
    "full_text": "RT @NYMag: James D. Walsh reports on the Adderall shortage. Ascent Pharmaceuticals’s feud with the DEA is exacerbating the ADHD medication…",
    "lang": "en"
  }
}